Ute Schütte

Ferroptosis regulation by the NGLY1/NFE2L1 pathway

Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-term Growth

Ferroptosis: molecular mechanisms and health implications

Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model

Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty

Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?

Immunotherapy coming of age: What will it take to make it standard of care for glioblastoma?

Tumour heterogeneity and cancer cell plasticity

Broadening horizons: the role of ferroptosis in cancer

The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma

Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy

Targeting ferroptosis as a vulnerability in cancer

Ferroptosis: mechanisms, biology and role in disease

The Fibroblast Growth Factor signaling pathway

TIMER2.0 for analysis of tumor-infiltrating immune cells

Cellular and molecular mechanisms in cancer immune escape: a comprehensive review

Chromone: A Valid Scaffold in Medicinal Chemistry

Salinomycin as a Drug for Targeting Human Cancer Stem Cells

Precision glycocalyx editing as a strategy for cancer immunotherapy

Multi-targeted therapy of cancer by niclosamide: A new application for an old drug

Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells

Hippo Signaling Mediates Proliferation, Invasiveness, and Metastatic Potential of Clear Cell Renal Cell Carcinoma

Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma